Quest Diagnostics DGX
NYSE DGX
$233.27 +2.18 (+0.94%)
At close: Oct 2, 2026 · 4:00 PM EDT

Quest Diagnostics (DGX) Gains from Sales and Divestitures (2013 - 2017)

Updated

Quest Diagnostics' Gains from Sales and Divestitures came in at -$9 million for FY2021, compared with -$3 million in FY2020.

Analysis

Quest Diagnostics (DGX) Gains from Sales and Divestitures (2013 - 2017) Analysis & Trends

Going back to FY2015, Quest Diagnostics' Gains from Sales and Divestitures data covers 7 years.

  • The FY2021 figure represents the lowest annual Gains from Sales and Divestitures in data going back to FY2015.
  • Per Business Quant, earlier years put Gains from Sales and Divestitures at -$3 million in FY2020, $70 million in FY2019, -$6 million in FY2018 and -$2 million in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 93.08 Bn 92.52 Bn -
2 Natera 58.93 Bn 54.61 Bn 485.19 Mn
3 Quest Diagnostics 25.75 Bn 24.18 Bn 1.03 Bn
4 Labcorp Holdings 24.96 Bn 22.73 Bn 1.11 Bn
5 Guardant Health 23.76 Bn 19.82 Bn 219.03 Mn
6 Tenet Healthcare 20.83 Bn 11.98 Bn -
7 Tempus AI 13.43 Bn 10.46 Bn 246.50 Mn
8 BrightSpring Health Services 11.90 Bn 10.24 Bn 492.75 Mn
9 Encompass Health 11.82 Bn 12.29 Bn -
10 Davita 11.43 Bn 10.20 Bn 1.16 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 -2.00 Mn
Jun 30, 2016 118.00 Mn
Sep 30, 2015 334.00 Mn
Dec 31, 2013 17.00 Mn
Sep 30, 2013 -39.00 Mn
API Access

Quest Diagnostics Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=DGX&period=max&api_key=YOUR_API_KEY